Literature DB >> 8316064

Superparamagnetic iron oxides as positive MR contrast agents: in vitro and in vivo evidence.

C Chambon1, O Clement, A Le Blanche, E Schouman-Claeys, G Frija.   

Abstract

The ability of superparamagnetic iron oxides (SPIO) and ultrasmall superparamagnetic iron oxides (USPIO) to act as positive contrast enhancers due to a marked T1 relaxivity was investigated. At low concentrations, an important signal enhancement was observed in vitro, reaching 120% for SPIO and 140% for USPIO in a spin echo 500/22 sequence. The more heavily the sequence was T1-weighted the greater the enhancement. As the concentration increased, the signal dropped. The in vivo study of USPIO in the rat showed that at low doses (14 mumol Fe/kg), the myocardial signal was enhanced by 30%, whereas at high doses (77 mumol Fe/kg), it fell by -50%. These results indicate that in T1-weighted spin echo sequences, the MR signal can be enhanced by low concentrations of superparamagnetic compounds. This effect could be useful in perfusion imaging, and is also important for a better understanding of any possible paradoxical positive enhancement which could occur in perfused organs.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8316064     DOI: 10.1016/0730-725x(93)90470-x

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  25 in total

1.  T₁-weighted ultrashort echo time method for positive contrast imaging of magnetic nanoparticles and cancer cells bound with the targeted nanoparticles.

Authors:  Longjiang Zhang; Xiaodong Zhong; Liya Wang; Hongwei Chen; Y Andrew Wang; Julie Yeh; Lily Yang; Hui Mao
Journal:  J Magn Reson Imaging       Date:  2011-01       Impact factor: 4.813

Review 2.  [Molecular and parametric imaging with iron oxides].

Authors:  L Matuszewski; B Tombach; W Heindel; C Bremer
Journal:  Radiologe       Date:  2007-01       Impact factor: 0.635

3.  Characterization of carotid artery plaques with USPIO-enhanced MRI: assessment of inflammation and vascularity as in vivo imaging biomarkers for plaque vulnerability.

Authors:  Stephan Metz; Ambros J Beer; Marcus Settles; Jaroslav Pelisek; René M Botnar; Ernst J Rummeny; Peter Heider
Journal:  Int J Cardiovasc Imaging       Date:  2010-10-24       Impact factor: 2.357

4.  Retraction by surface ferromagnetisation of target tissues: preliminary studies on feasibility of magnetic retraction for endoscopic surgery.

Authors:  Zhigang Wang; Lijun Wang; Benjie Tang; Timothy Frank; Stuart Brown; Alfred Cuschieri
Journal:  Surg Endosc       Date:  2007-12-11       Impact factor: 4.584

5.  Fluorochrome-functionalized nanoparticles for imaging DNA in biological systems.

Authors:  Hoonsung Cho; David Alcantara; Hushan Yuan; Rahul A Sheth; Howard H Chen; Peng Huang; Sean B Andersson; David E Sosnovik; Umar Mahmood; Lee Josephson
Journal:  ACS Nano       Date:  2013-02-07       Impact factor: 15.881

6.  Dosage determination of ultrasmall particles of iron oxide for the delineation of microvasculature in the Wistar rat brain.

Authors:  Ming Yang; Gregory A Christoforidis; Tatiana Figueredo; Johannes T Heverhagen; Amir Abduljalil; Michael V Knopp
Journal:  Invest Radiol       Date:  2005-10       Impact factor: 6.016

7.  Dose and scanning delay using USPIO for central nervous system macrophage imaging.

Authors:  V Dousset; C Gomez; K G Petry; C Delalande; J M Caille
Journal:  MAGMA       Date:  1999-08       Impact factor: 2.310

Review 8.  In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles.

Authors:  Hamed Arami; Amit Khandhar; Denny Liggitt; Kannan M Krishnan
Journal:  Chem Soc Rev       Date:  2015-09-21       Impact factor: 54.564

9.  Ultrashort echo time (UTE) imaging of receptor targeted magnetic iron oxide nanoparticles in mouse tumor models.

Authors:  Liya Wang; Xiaodong Zhong; Weiping Qian; Jing Huang; Zehong Cao; Qiqi Yu; Malgorzata Lipowska; Run Lin; Andrew Wang; Lily Yang; Hui Mao
Journal:  J Magn Reson Imaging       Date:  2014-11       Impact factor: 4.813

10.  Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro.

Authors:  Stephan Metz; Gabriel Bonaterra; Martina Rudelius; Marcus Settles; Ernst J Rummeny; Heike E Daldrup-Link
Journal:  Eur Radiol       Date:  2004-07-13       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.